Friday, October 30, 2026Eastern Time · Updated through the dayRSS

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Lilly says ‘triple-G’ drug beat Novo’s Ozempic in diabetes study

MH

By Maren Holt · Senior Reporter, GLP-1

Oct 28 06:46 ETSource: STAT

From the source

Lilly says ‘triple-G’ drug beat Novo’s Ozempic in diabetes study

Read at statnews.com

Source URL https://www.statnews.com/2026/10/28/retatrutide-vs-ozempic-lilly-diabetes-study/

Prescribed peptides from $99/moSee all →